APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma Therapy

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

Selected research

Market Analysis & Forecast

Global Plasma Therapy Market Analysis and Forecast 2026-2032

20 December 2025196 pages

Choose your research edition.

Industry ResearchPlasma Therapy Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Therapy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Plasma Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Therapy Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Therapy Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

North America is the largest consumption place, with a consumption market share nearly 53% . Europe is the second largest consumption place with the consumption market share of 26%. Terumo, Arthrex, Zimmer Biomet, DePuy Synthes and EmCyte are the leaders of the industry, top 3 companies occupied about 55% market share.

Report Includes

Read the full market overview

This report presents an overview of global market for Plasma Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plasma Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Plasma Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plasma Therapy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasma Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Plasma Therapy revenue, projected growth trends, production technology, application and end-user industry.

Plasma Therapy Segment by Company

Terumo

Arthrex

Zimmer Biomet

DePuy Synthes

EmCyte

Regen Lab

ISTO Biologics

Cesca Therapeutics

Weigao

REV-MED

Nuo Therapeutics

Plasma Therapy Segment by Type

Pure PRP

Leucocyte-rich PRP

Leukocyte-rich Fibrin (L-PRF)

Plasma Therapy Segment by Application

Orthopedic

Darmatology

Cardiac Muscle Injury

Dental

Nerve Injury

Plasma Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Plasma Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Plasma Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Therapy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plasma Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pure PRP Major Player Table 3. Leucocyte-rich PRP Major Player Table 4. Leukocyte-rich Fibrin (L-PRF) Major Player Table 5. Global Plasma Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Orthopedic Major Player Table 7. Darmatology Major Player Table 8. Cardiac Muscle Injury Major Player Table 9. Dental Major Player Table 10. Nerve Injury Major Player Table 11. Plasma Therapy Industry Trends Table 12. Plasma Therapy Industry Drivers Table 13. Plasma Therapy Industry Opportunities and Challenges Table 14. Plasma Therapy Industry Restraints Table 15. Global Plasma Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Plasma Therapy Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Plasma Therapy Market Share by Region (2021-2026) Table 18. Global Plasma Therapy Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Plasma Therapy Market Share by Region (2027-2032) Table 20. Global Plasma Therapy Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Plasma Therapy Revenue Market Share by Players (2021-2026) Table 22. Global Plasma Therapy Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Plasma Therapy Key Players Headquarters & Area Served Table 24. Global Plasma Therapy Players, Product Type & Application Table 25. Global Plasma Therapy Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Plasma Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Plasma Therapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Plasma Therapy Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Plasma Therapy Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Plasma Therapy Revenue Market Share by Type (2021-2026) Table 32. Global Plasma Therapy Revenue Market Share by Type (2027-2032) Table 33. Global Plasma Therapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Plasma Therapy Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Plasma Therapy Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Plasma Therapy Revenue Market Share by Application (2021-2026) Table 37. Global Plasma Therapy Revenue Market Share by Application (2027-2032) Table 38. Terumo Company Information Table 39. Terumo Business Overview Table 40. Terumo Plasma Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Terumo Plasma Therapy Product Portfolio Table 42. Terumo Recent Development Table 43. Arthrex Company Information Table 44. Arthrex Business Overview Table 45. Arthrex Plasma Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Arthrex Plasma Therapy Product Portfolio Table 47. Arthrex Recent Development Table 48. Zimmer Biomet Company Information Table 49. Zimmer Biomet Business Overview Table 50. Zimmer Biomet Plasma Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Zimmer Biomet Plasma Therapy Product Portfolio Table 52. Zimmer Biomet Recent Development Table 53. DePuy Synthes Company Information Table 54. DePuy Synthes Business Overview Table 55. DePuy Synthes Plasma Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. DePuy Synthes Plasma Therapy Product Portfolio Table 57. DePuy Synthes Recent Development Table 58. EmCyte Company Information Table 59. EmCyte Business Overview Table 60. EmCyte Plasma Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. EmCyte Plasma Therapy Product Portfolio Table 62. EmCyte Recent Development Table 63. Regen Lab Company Information Table 64. Regen Lab Business Overview Table 65. Regen Lab Plasma Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Regen Lab Plasma Therapy Product Portfolio Table 67. Regen Lab Recent Development Table 68. ISTO Biologics Company Information Table 69. ISTO Biologics Business Overview Table 70. ISTO Biologics Plasma Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. ISTO Biologics Plasma Therapy Product Portfolio Table 72. ISTO Biologics Recent Development Table 73. Cesca Therapeutics Company Information Table 74. Cesca Therapeutics Business Overview Table 75. Cesca Therapeutics Plasma Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Cesca Therapeutics Plasma Therapy Product Portfolio Table 77. Cesca Therapeutics Recent Development Table 78. Weigao Company Information Table 79. Weigao Business Overview Table 80. Weigao Plasma Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Weigao Plasma Therapy Product Portfolio Table 82. Weigao Recent Development Table 83. REV-MED Company Information Table 84. REV-MED Business Overview Table 85. REV-MED Plasma Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. REV-MED Plasma Therapy Product Portfolio Table 87. REV-MED Recent Development Table 88. Nuo Therapeutics Company Information Table 89. Nuo Therapeutics Business Overview Table 90. Nuo Therapeutics Plasma Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Nuo Therapeutics Plasma Therapy Product Portfolio Table 92. Nuo Therapeutics Recent Development Table 93. North America Plasma Therapy Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Plasma Therapy Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Plasma Therapy Revenue by Application (2021-2026) & (US$ Million) Table 96. North America Plasma Therapy Revenue by Application (2027-2032) & (US$ Million) Table 97. North America Plasma Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Plasma Therapy Revenue by Country (2021-2026) & (US$ Million) Table 99. North America Plasma Therapy Revenue by Country (US$ Million) & (2027-2032) Table 100. Europe Plasma Therapy Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Plasma Therapy Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Plasma Therapy Revenue by Application (2021-2026) & (US$ Million) Table 103. Europe Plasma Therapy Revenue by Application (2027-2032) & (US$ Million) Table 104. Europe Plasma Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Europe Plasma Therapy Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Plasma Therapy Revenue by Country (US$ Million) & (2027-2032) Table 107. China Plasma Therapy Revenue by Type (2021-2026) & (US$ Million) Table 108. China Plasma Therapy Revenue by Type (2027-2032) & (US$ Million) Table 109. China Plasma Therapy Revenue by Application (2021-2026) & (US$ Million) Table 110. China Plasma Therapy Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Plasma Therapy Revenue by Type (2021-2026) & (US$ Million) Table 112. Asia Plasma Therapy Revenue by Type (2027-2032) & (US$ Million) Table 113. Asia Plasma Therapy Revenue by Application (2021-2026) & (US$ Million) Table 114. Asia Plasma Therapy Revenue by Application (2027-2032) & (US$ Million) Table 115. Asia Plasma Therapy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Asia Plasma Therapy Revenue by Region (US$ Million) & (2021-2026) Table 117. Asia Plasma Therapy Revenue by Region (US$ Million) & (2027-2032) Table 118. SAMEA Plasma Therapy Revenue by Type (2021-2026) & (US$ Million) Table 119. SAMEA Plasma Therapy Revenue by Type (2027-2032) & (US$ Million) Table 120. SAMEA Plasma Therapy Revenue by Application (2021-2026) & (US$ Million) Table 121. SAMEA Plasma Therapy Revenue by Application (2027-2032) & (US$ Million) Table 122. SAMEA Plasma Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. SAMEA Plasma Therapy Revenue by Country (2021-2026) & (US$ Million) Table 124. SAMEA Plasma Therapy Revenue by Country (US$ Million) & (2027-2032) Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Plasma Therapy Image Figure 2. Global Plasma Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pure PRP Image Figure 5. Leucocyte-rich PRP Image Figure 6. Leukocyte-rich Fibrin (L-PRF) Image Figure 7. Global Plasma Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Plasma Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 9. Orthopedic Image Figure 10. Darmatology Image Figure 11. Cardiac Muscle Injury Image Figure 12. Dental Image Figure 13. Nerve Injury Image Figure 14. Global Plasma Therapy Market Size (US$ Million) & (2021-2032) Figure 15. Global Plasma Therapy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Plasma Therapy Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Plasma Therapy Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Plasma Therapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Plasma Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Plasma Therapy Revenue Market Share by Type (2021-2032) Figure 22. Global Plasma Therapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Plasma Therapy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Plasma Therapy Revenue Market Share by Application (2021-2032) Figure 25. North America Plasma Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Plasma Therapy Revenue Share by Type (2021-2032) Figure 27. North America Plasma Therapy Revenue Share by Application (2021-2032) Figure 28. North America Plasma Therapy Revenue Share by Country (2021-2032) Figure 29. United States Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Plasma Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Plasma Therapy Revenue Share by Type (2021-2032) Figure 34. Europe Plasma Therapy Revenue Share by Application (2021-2032) Figure 35. Europe Plasma Therapy Revenue Share by Country (2021-2032) Figure 36. Germany Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Plasma Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Plasma Therapy Revenue Share by Type (2021-2032) Figure 46. China Plasma Therapy Revenue Share by Application (2021-2032) Figure 47. Asia Plasma Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Plasma Therapy Revenue Share by Type (2021-2032) Figure 49. Asia Plasma Therapy Revenue Share by Application (2021-2032) Figure 50. Asia Plasma Therapy Revenue Share by Region (2021-2032) Figure 51. Japan Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Plasma Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Plasma Therapy Revenue Share by Type (2021-2032) Figure 59. SAMEA Plasma Therapy Revenue Share by Application (2021-2032) Figure 60. SAMEA Plasma Therapy Revenue Share by Country (2021-2032) Figure 61. Brazil Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Plasma Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Pure PRP
  • Leucocyte-rich PRP
  • Leukocyte-rich Fibrin (L-PRF)
Applications
  • Orthopedic
  • Darmatology
  • Cardiac Muscle Injury
  • Dental
  • Nerve Injury
Companies covered
  • Terumo
  • Arthrex
  • Zimmer Biomet
  • DePuy Synthes
  • EmCyte
  • Regen Lab
  • ISTO Biologics
  • Cesca Therapeutics
  • Weigao
  • REV-MED
  • Nuo Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plasma Therapy Market by Type
  3. 1.2.1 Global Plasma Therapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pure PRP
  5. 1.2.3 Leucocyte-rich PRP
  6. 1.2.4 Leukocyte-rich Fibrin (L-PRF)
  7. 1.3 Plasma Therapy Market by Application
  8. 1.3.1 Global Plasma Therapy Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Orthopedic
  10. 1.3.3 Darmatology
  11. 1.3.4 Cardiac Muscle Injury
  12. 1.3.5 Dental
  13. 1.3.6 Nerve Injury
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Plasma Therapy Market Dynamics
  1. 2.1 Plasma Therapy Industry Trends
  2. 2.2 Plasma Therapy Industry Drivers
  3. 2.3 Plasma Therapy Industry Opportunities and Challenges
  4. 2.4 Plasma Therapy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Plasma Therapy Market Perspective (2021-2032)
  2. 3.2 Global Plasma Therapy Growth Trends by Region
  3. 3.2.1 Global Plasma Therapy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plasma Therapy Market Size by Region (2021-2026)
  5. 3.2.3 Global Plasma Therapy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Plasma Therapy Revenue by Players
  2. 4.1.1 Global Plasma Therapy Revenue by Players (2021-2026)
  3. 4.1.2 Global Plasma Therapy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Plasma Therapy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plasma Therapy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Plasma Therapy Key Players Headquarters & Area Served
  7. 4.4 Global Plasma Therapy Players, Product Type & Application
  8. 4.5 Global Plasma Therapy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Plasma Therapy Market CR5 and HHI
  11. 4.6.3 2025 Plasma Therapy Tier 1, Tier 2, and Tier 3
5 Plasma Therapy Market Size by Type
  1. 5.1 Global Plasma Therapy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Plasma Therapy Revenue by Type (2021-2032)
  3. 5.3 Global Plasma Therapy Revenue Market Share by Type (2021-2032)
6 Plasma Therapy Market Size by Application
  1. 6.1 Global Plasma Therapy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Plasma Therapy Revenue by Application (2021-2032)
  3. 6.3 Global Plasma Therapy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Terumo
  2. 7.1.1 Terumo Company Information
  3. 7.1.2 Terumo Business Overview
  4. 7.1.3 Terumo Plasma Therapy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Terumo Plasma Therapy Product Portfolio
  6. 7.1.5 Terumo Recent Developments
  7. 7.2 Arthrex
  8. 7.2.1 Arthrex Company Information
  9. 7.2.2 Arthrex Business Overview
  10. 7.2.3 Arthrex Plasma Therapy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Arthrex Plasma Therapy Product Portfolio
  12. 7.2.5 Arthrex Recent Developments
  13. 7.3 Zimmer Biomet
  14. 7.3.1 Zimmer Biomet Company Information
  15. 7.3.2 Zimmer Biomet Business Overview
  16. 7.3.3 Zimmer Biomet Plasma Therapy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Zimmer Biomet Plasma Therapy Product Portfolio
  18. 7.3.5 Zimmer Biomet Recent Developments
  19. 7.4 DePuy Synthes
  20. 7.4.1 DePuy Synthes Company Information
  21. 7.4.2 DePuy Synthes Business Overview
  22. 7.4.3 DePuy Synthes Plasma Therapy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 DePuy Synthes Plasma Therapy Product Portfolio
  24. 7.4.5 DePuy Synthes Recent Developments
  25. 7.5 EmCyte
  26. 7.5.1 EmCyte Company Information
  27. 7.5.2 EmCyte Business Overview
  28. 7.5.3 EmCyte Plasma Therapy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 EmCyte Plasma Therapy Product Portfolio
  30. 7.5.5 EmCyte Recent Developments
  31. 7.6 Regen Lab
  32. 7.6.1 Regen Lab Company Information
  33. 7.6.2 Regen Lab Business Overview
  34. 7.6.3 Regen Lab Plasma Therapy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Regen Lab Plasma Therapy Product Portfolio
  36. 7.6.5 Regen Lab Recent Developments
  37. 7.7 ISTO Biologics
  38. 7.7.1 ISTO Biologics Company Information
  39. 7.7.2 ISTO Biologics Business Overview
  40. 7.7.3 ISTO Biologics Plasma Therapy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ISTO Biologics Plasma Therapy Product Portfolio
  42. 7.7.5 ISTO Biologics Recent Developments
  43. 7.8 Cesca Therapeutics
  44. 7.8.1 Cesca Therapeutics Company Information
  45. 7.8.2 Cesca Therapeutics Business Overview
  46. 7.8.3 Cesca Therapeutics Plasma Therapy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Cesca Therapeutics Plasma Therapy Product Portfolio
  48. 7.8.5 Cesca Therapeutics Recent Developments
  49. 7.9 Weigao
  50. 7.9.1 Weigao Company Information
  51. 7.9.2 Weigao Business Overview
  52. 7.9.3 Weigao Plasma Therapy Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Weigao Plasma Therapy Product Portfolio
  54. 7.9.5 Weigao Recent Developments
  55. 7.10 REV-MED
  56. 7.10.1 REV-MED Company Information
  57. 7.10.2 REV-MED Business Overview
  58. 7.10.3 REV-MED Plasma Therapy Revenue and Gross Margin (2021-2026)
  59. 7.10.4 REV-MED Plasma Therapy Product Portfolio
  60. 7.10.5 REV-MED Recent Developments
  61. 7.11 Nuo Therapeutics
  62. 7.11.1 Nuo Therapeutics Company Information
  63. 7.11.2 Nuo Therapeutics Business Overview
  64. 7.11.3 Nuo Therapeutics Plasma Therapy Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Nuo Therapeutics Plasma Therapy Product Portfolio
  66. 7.11.5 Nuo Therapeutics Recent Developments
8 North America
  1. 8.1 North America Plasma Therapy Revenue (2021-2032)
  2. 8.2 North America Plasma Therapy Revenue by Type (2021-2032)
  3. 8.2.1 North America Plasma Therapy Revenue by Type (2021-2026)
  4. 8.2.2 North America Plasma Therapy Revenue by Type (2027-2032)
  5. 8.3 North America Plasma Therapy Revenue Share by Type (2021-2032)
  6. 8.4 North America Plasma Therapy Revenue by Application (2021-2032)
  7. 8.4.1 North America Plasma Therapy Revenue by Application (2021-2026)
  8. 8.4.2 North America Plasma Therapy Revenue by Application (2027-2032)
  9. 8.5 North America Plasma Therapy Revenue Share by Application (2021-2032)
  10. 8.6 North America Plasma Therapy Revenue by Country
  11. 8.6.1 North America Plasma Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Plasma Therapy Revenue by Country (2021-2026)
  13. 8.6.3 North America Plasma Therapy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Plasma Therapy Revenue (2021-2032)
  2. 9.2 Europe Plasma Therapy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Plasma Therapy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Plasma Therapy Revenue by Type (2027-2032)
  5. 9.3 Europe Plasma Therapy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Plasma Therapy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Plasma Therapy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Plasma Therapy Revenue by Application (2027-2032)
  9. 9.5 Europe Plasma Therapy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Plasma Therapy Revenue by Country
  11. 9.6.1 Europe Plasma Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Plasma Therapy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Plasma Therapy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Plasma Therapy Revenue (2021-2032)
  2. 10.2 China Plasma Therapy Revenue by Type (2021-2032)
  3. 10.2.1 China Plasma Therapy Revenue by Type (2021-2026)
  4. 10.2.2 China Plasma Therapy Revenue by Type (2027-2032)
  5. 10.3 China Plasma Therapy Revenue Share by Type (2021-2032)
  6. 10.4 China Plasma Therapy Revenue by Application (2021-2032)
  7. 10.4.1 China Plasma Therapy Revenue by Application (2021-2026)
  8. 10.4.2 China Plasma Therapy Revenue by Application (2027-2032)
  9. 10.5 China Plasma Therapy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plasma Therapy Revenue (2021-2032)
  2. 11.2 Asia Plasma Therapy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Plasma Therapy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Plasma Therapy Revenue by Type (2027-2032)
  5. 11.3 Asia Plasma Therapy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Plasma Therapy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Plasma Therapy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Plasma Therapy Revenue by Application (2027-2032)
  9. 11.5 Asia Plasma Therapy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Plasma Therapy Revenue by Country
  11. 11.6.1 Asia Plasma Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Plasma Therapy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Plasma Therapy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plasma Therapy Revenue (2021-2032)
  2. 12.2 SAMEA Plasma Therapy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Plasma Therapy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Plasma Therapy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Plasma Therapy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Plasma Therapy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Plasma Therapy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Plasma Therapy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Plasma Therapy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Plasma Therapy Revenue by Country
  11. 12.6.1 SAMEA Plasma Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Plasma Therapy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Plasma Therapy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst